01 2EMD Inc.
02 1EMD Serono
03 1EMD Serono Canada
01 22115943
02 22330131
01 4Cetrorelix Acetate
01 2Lyophilized powder for Injection
02 2Lyophilized powder for injection
01 22014-02-18
02 22019-03-29
Patent Expiration Date : 2014-02-18
Date Granted : 2003-08-05
Brand Name : CETROTIDE
Patent Number : 2115943
Filing Date : 1994-02-18
Strength per Unit : 3.0mg / vial
Dosage Form : Lyophilized powder for Injection
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2014-02-18
Date Granted : 2003-08-05
Patent Expiration Date : 2014-02-18
Date Granted : 2003-08-05
Brand Name : CETROTIDE
Patent Number : 2115943
Filing Date : 1994-02-18
Strength per Unit : 0.25mg / vial
Dosage Form : Lyophilized powder for injection
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2014-02-18
Date Granted : 2003-08-05
Patent Expiration Date : 2019-03-29
Date Granted : 2011-10-25
Brand Name : CETROTIDE
Patent Number : 2330131
Filing Date : 1999-03-29
Strength per Unit : 0.25mg / vial
Dosage Form : Lyophilized powder for injection
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2019-03-29
Date Granted : 2011-10-25
Patent Expiration Date : 2019-03-29
Date Granted : 2011-10-25
Brand Name : CETROTIDE
Patent Number : 2330131
Filing Date : 1999-03-29
Strength per Unit : 3.0mg / vial
Dosage Form : Lyophilized powder for Injection
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2019-03-29
Date Granted : 2011-10-25
